Wirth M - Search Results

1

Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?

Voigt S, Hüttig F, Koch R, Propping S, Propping C, Grimm MO, Wirth M. Voigt S, et al. Among authors: wirth m. Prostate. 2011 Sep;71(12):1325-31. doi: 10.1002/pros.21349. Epub 2011 Feb 9. Prostate. 2011. PMID: 21308716

2

Radical prostatectomy in patients with incidental prostate carcinoma.

Manseck A, Wirth M, Theiss M, Frohmüller H. Manseck A, et al. Among authors: wirth m. Urol Int. 1994;53(4):196-208. doi: 10.1159/000282672. Urol Int. 1994. PMID: 7531896 Review.

3

Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy.

Theiss M, Wirth MP, Manseck A, Frohmüller HG. Theiss M, et al. Among authors: wirth mp. Prostate. 1995 Jul;27(1):13-7. doi: 10.1002/pros.2990270104. Prostate. 1995. PMID: 7603912

4

Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma.

Froschermaier SE, Pilarsky CP, Wirth MP. Froschermaier SE, et al. Among authors: wirth mp. Urology. 1996 Apr;47(4):525-8. doi: 10.1016/S0090-4295(99)80488-9. Urology. 1996. PMID: 8638361

5

[Value of PSA density determination in prostate carcinoma].

Manseck A, Benusch T, Wirth M. Manseck A, et al. Among authors: wirth m. Urologe A. 1997 Jul;36(4):323-6. doi: 10.1007/s001200050105. Urologe A. 1997. PMID: 9340897 German.

6

Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.

Manseck A, Pilarsky C, Froschermaier S, Menschikowski M, Wirth MP. Manseck A, et al. Among authors: wirth mp. Urol Int. 1998;60(1):25-7. doi: 10.1159/000030198. Urol Int. 1998. PMID: 9519417 Clinical Trial.

7

Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.

Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP. Pilarsky CP, et al. Among authors: wirth mp. Prostate. 1998 Jul 1;36(2):85-91. doi: 10.1002/(sici)1097-0045(19980701)36:2<85::aid-pros3>3.0.co;2-d. Prostate. 1998. PMID: 9655260

8

[Screening in prostate carcinoma].

Wirth MP, Spiegel T, Froschermaier SE, Manseck A. Wirth MP, et al. Z Arztl Fortbild Qualitatssich. 1998 Jun;92(5):304-9. Z Arztl Fortbild Qualitatssich. 1998. PMID: 9702818 Review. German.

9

Favorable long-term outcome in adult genitourinary low-grade sarcoma.

Froehner M, Lossnitzer A, Manseck A, Koch R, Noack B, Wirth MP. Froehner M, et al. Among authors: wirth mp. Urology. 2000 Sep 1;56(3):373-7. doi: 10.1016/s0090-4295(00)00704-4. Urology. 2000. PMID: 10962297

10

Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia.

Hakenberg OW, Helke C, Manseck A, Wirth MP. Hakenberg OW, et al. Among authors: wirth mp. Eur Urol. 2001 Apr;39(4):412-7. doi: 10.1159/000052478. Eur Urol. 2001. PMID: 11306879 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,542 results

Search Page

Filters